| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.bafnapharma.com | |
| Market Cap | 206.52 Cr. | |
| Enterprise Value(EV) | 223.10 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 4.76 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 18.34 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.01 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 33.57 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.60 | Calculated using Price: 87.30 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 2.37 Cr. | 23,656,335 Shares |
| FaceValue | 10 | |
| About Bafna Pharmaceuticals Ltd. | ||
| Bafna Pharmaceuticals was incepted by Bafna Mahaveer Chand in 1981 as a proprietary concern. It was converted into a public limited company on 28th march 1995. The company started its own manufacturing unit in October 1984. | ||
| 1 Day |
|
|
| 1 Week |
|
-1.91% |
| 1 Month |
|
+9.04% |
| 3 Month |
|
-11.92% |
| 6 Month |
|
-0.39% |
| 1 Year |
|
+3.00% |
| 2 Year |
|
-32.27% |
| 5 Year |
|
+826.75% |
| 10 Year |
|
+254.88% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 9.22 | -18.69 | -37.05 | -40.37 | -64.36 | -22.93 | 22.26 | 8.79 | 16.75 | |
| Return on Capital Employed (%) | 12.56 | -0.04 | -5.98 | -6.97 | -20.9 | -2.95 | 10.62 | 8.42 | 16.12 | |
| Return on Assets (%) | 2.99 | -6.58 | -10.49 | -11.17 | -15.9 | -1.96 | 7.4 | 5.91 | 10.32 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 72 | 59 | 45 | 41 | 21 | 51 | 57 | 62 | 73 | 82 | |
| Non Curr. Liab. | 14 | 39 | 42 | 28 | 29 | 3 | 5 | 6 | 10 | 8 | |
| Curr. Liab. | 100 | 87 | 81 | 59 | 71 | 17 | 24 | 22 | 46 | 44 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 185 | 185 | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 135 | |
| Non Curr. Assets | 68 | 65 | 90 | 79 | 72 | 35 | 37 | 39 | 42 | 44 | |
| Curr. Assets | 117 | 119 | 77 | 48 | 48 | 36 | 50 | 51 | 87 | 91 | |
| Misc. Exp. not W/O | 1 | ||||||||||
| Total Assets | 185 | 185 | 167 | 128 | 121 | 71 | 86 | 90 | 130 | 135 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 143 | 85 | 65 | 47 | 44 | 42 | 71 | 85 | 115 | 153 | |
| Other Income | 1 | 1 | 1 | 31 | 0 | 0 | 1 | 2 | 3 | 3 | |
| Total Income | 144 | 87 | 66 | 78 | 44 | 43 | 72 | 87 | 119 | 157 | |
| Total Expenditure | -117 | -83 | -70 | -82 | -57 | -41 | -61 | -73 | -100 | -137 | |
| PBIDT | 26 | 4 | -4 | -4 | -13 | 1 | 11 | 14 | 19 | 19 | |
| Interest | -12 | -12 | -11 | -7 | -2 | 0 | -1 | -1 | -2 | -2 | |
| Depreciation | -5 | -4 | -4 | -4 | -3 | -3 | -4 | -5 | -5 | -5 | |
| Taxation | 0 | 0 | 1 | -2 | -2 | 0 | 0 | ||||
| Exceptional Items | -3 | -2 | |||||||||
| PAT | 6 | -12 | -18 | -16 | -20 | -2 | 6 | 5 | 11 | 11 | |
| Adjusted EPS | 3 | -7 | -10 | -7 | -8 | -8 | 2 | 2 | 5 | 5 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 9 | -3 | 20 | -7 | -1 | -34 | -14 | 10 | 5 | |
| Cash Fr. Inv. | -5 | 56 | -1 | -14 | 38 | 4 | 33 | -5 | -7 | -7 | |
| Cash Fr. Finan. | -14 | -66 | 4 | -5 | -31 | -2 | 7 | 12 | -5 | 10 | |
| Net Change | -18 | 0 | 0 | 0 | 0 | 6 | -7 | -2 | 8 | ||
| Cash & Cash Eqvt | 2 | 2 | 3 | 3 | 3 | 3 | 8 | 2 | 0 | 8 |
|
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 We are herewith enclosing Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for Quarter ended 31st March 2024. |
|
Mon, 25 Mar 2024
Closure of Trading Window The Trading Window for the designated persons connected persons shall remain closed from Sunday March 31 2024 up to 48 hours after the declaration of Financial results of the Company by the Board of directors for the quarter and year ending March 31 2024. |
|
Wed, 14 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication we have furnished herewith newspaper clippings of Un-audited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2023 which was approved by the Board in its meeting held on February 12 2024 and published in the newspapers namely in Makkal Kural (Tamil edition) and Business Standard (English edition) on Tuesday February 13 2024. |
| Thu, 18 Apr 2024 |
Opening at High
|
Opening at Low
|
Close Within 52 Week Low Zone
|
High Decrease in 3 Months
|
High Increase in 5 Years
|
